Product Name | CAS No. | Monograph | Status |
Ambroxol Hydrochloride | 23828-92-4 | IP/USP/BP/EP | Commercial |
Etoricoxib | 202409-33-4 | IHS/IP | Commercial |
Niclosamide | 50-65-7 | IP/EP/BP | Commercial |
Etodolac | 41340-25-4 | - | Under Scale Up |
Telmisartan | 144701-48-4 | - | Under Validation |
Sitagliptin | 486460-32-6 | - | Under Development |
Product Name | Cas No | Structure | Details |
BILASTINE | 202189-78-4 | ||
CELECOXIB | 169590-42-5 | ||
GABAPENTINE | 60142-96-3 | ||
FLUOXETINE HCL | 56296-78-7 | ||
FLUCONAZOLE | 86386-73-4 | ||
LACOSAMIDE | 175481-36-4 | ||
MEBEVERINE | 3625-06-7 | ||
MONTILUKAST | 158966-92-8 | ||
OXICONAZOLE NITRATE | 64211-46-7 | ||
NAPROXEN SODIUM | 26159-34-2 | ||
RISPERIDONE | 106266-06-2 | ||
RIVAROXABAN | 366789-02-8 | ||
RUPATADINE | 158876-82-5 | ||
SITAGLIPTIN | 486460-32-6 | ||
TIOCONAZOLE | 65899-73-2 | ||
TRANEXAMIC ACID | 1197-18-8 |
Raveez Pharma has been working with a clear corporate vision and values. We believe in working hard together to achieve our goal.